Month: December 2020
Den verserende Corona pandemi har også påvirket FastPassCorp i negativ retning. Det har stort set vist sig umuligt at etablere salgs møder med kunder og potentielle kunder. Dette har betydet en forringelse i forhold til den forventning, vi meldte ud i forbindelse med delrapport for første halvår.For året som helhed forventer vi nu – i bedste fald – en marginal vækst og et resultat før skat omkring plus/minus 0. Vedhæftet fil151220 FN10 Ændret resultatforventning
[Communiqué de presse Free] Free : la 5G sans surcoût sur le plus grand réseau 5G de France
Written by Customer Service on . Posted in Public Companies.
COMMUNIQUE DE PRESSE Free : la 5G sans surcoût sur le plus grand réseau 5G de FranceFree lance aujourd’hui la 5G et propose le seul Forfait qui inclut la 5G sans surcoût, avec l’Internet mobile illimité pour les abonnés Freebox. Free opère le plus grand réseau 5G en France avec 5 255 sites actifs couvrant déjà près de 40% de la population. Free rend ainsi la 5G accessible aux français. La 5G sans surcoûtFidèle à son histoire, Free a décidé de démocratiser l’accès à la 5G en maintenant ses prix, en augmentant le volume de données (fair use data) et en incluant la 5G dans le Forfait Free. Le plus grand réseau mobile 5G de France Avec 5 255 sites actifs, c’est près de 40% de la population qui est déjà couverte. Free dispose ainsi aujourd’hui du plus grand réseau mobile 5G en France qui couvre à la fois des territoires ruraux et des zones...
SaraRasa will expand its production capacity in Indonesia
Written by Customer Service on . Posted in Public Companies.
Dovre Group Plc Stock Exchange Release December 15, 2020 at 9.10 amSaraRasa will expand its production capacity in IndonesiaDovre Group’s partly owned equity investment (ownership 19.86%) SaraRasa Bioindo Pte. Ltd.’s fully owned subsidiary PT SaraRasa Biomass (Company) has decided to expand its production at the factory site in Surabaya.The current production capacity will increase by over 20% and the warehouse storage capacity by over 100% compared to 2020. The new production construction is expected to be completed by August 2021. The expansion at the current site is expected to improve the profitability of the factory due to economy of scale and will be financed with Company’s excess cash reserves.For further information, please contact:Dovre Group PlcSirpa Haavisto, CFOsirpa.haavisto@dovregroup.comDovre...
SaraRasa laajentaa tuotantoaan Indonesiassa
Written by Customer Service on . Posted in Public Companies.
Dovre Group Oyj Pörssitiedote 15.12.2020 klo 9.10SaraRasa laajentaa tuotantoaan IndonesiassaDovre Groupin oman pääoman ehtoisen sijoituksen (omistusosuus 19,86 %) SaraRasa Bioindo Pte. Ltd:n kokonaan omistama tytäryhtiö PT SaraRasa Biomass (Yhtiö) on päättänyt laajentaa tuotantoaan tehdaslokaatiossaan Surabayassa.Nykyinen tuotantokapasiteetti nousee yli 20 %:a ja varastointikapasiteetti yli 100 %:a verrattuna vuoteen 2020. Tehtaan laajennusosan odotetaan olevan valmis elokuuhun 2021 mennessä. Nykyisen tehtaan laajentamisen odotetaan parantavan tehtaan kannattavuutta mittakaavaetujen ansiosta ja se rahoitetaan Yhtiön ylimääräisillä kassavaroilla.Lisätietoja:SaraRasa Bioindo Pte. Ltd.Ilari Koskelo, johtajailari.koskelo@navdata.fiDovre Group OyjSirpa Haavisto, talousjohtajasirpa.haavisto@dovregroup.comDovre...
BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application
Written by Customer Service on . Posted in Mergers And Acquisitions.
VANCOUVER, Dec. 14, 2020 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on the development and commercialization of cutting edge treatments, today announced the value proposition of its acquisition of Transcend Biodynamics, LLC’s (“Transcend”) manufacturing patent “Process of synthesizing 2-Bromo-LSD.” While the medicalization of psychedelics is evolving and gaining momentum at an extraordinary pace, such therapeutics still face regulatory hurdles in the areas of manufacturing, formulating, and ultimately dispensing or the rescheduling of Schedule I drugs to patients. Attaining the goals of any given psychedelic-based endeavour will require the removal of federally scheduled enforcement status and global United Nations drug conventions...
Vow ASA : Vow ASA launches Vow Industries and signs letters of intent for pioneering environmental industry at Follum, Norway
Written by Customer Service on . Posted in Public Companies.
Vow has decided to establish a new subsidiary, Vow Industries, which will accelerate the green shift in the industry. The company will develop, own and operate facilities based on Vow’s process technology. Vow Industries’ first goal is to build a factory to produce biocarbon for the metallurgical industry, CO2-neutral gas for district heating and biofuel for the petrochemical industry.As part of this initiative, Vow has agreed letters of intent with the forest owners’ association Viken Skog and the district heating company Vardar Varme. Both are central to the realization of the new factory. Viken Skog will supply biomass to the factory, which in turn will supply clean and CO2-neutral gas to Vardar Varme’s district heating plant. Vow is also in dialogue with companies in the metallurgical industry about the sale of biocarbon,...
BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules [Revised]
Written by Customer Service on . Posted in Public Companies.
SAN CARLOS, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc. (Nasdaq: BCDA)(BioCardia or the “Company”) today announced it has entered into definitive agreements with investors for the purchase and sale of 1,789,474 shares of its common stock at a purchase price of $4.75 per share in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to occur on or about December 16, 2020, subject to the satisfaction of customary closing conditions.A.G.P./Alliance Global Partners is acting as sole placement agent for the offering. This offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-249426) previously filed with the U.S. Securities and Exchange Commission (the “SEC”). A prospectus supplement describing the terms of the proposed...
Meteorological Equipment Market to Reach USD 3.11 Billion by 2027; Adoption of Next-generation Workstations to Aid Growth: Fortune Business Insights™
Written by Customer Service on . Posted in Mergers And Acquisitions.
Pune, Dec. 15, 2020 (GLOBE NEWSWIRE) — The global meteorological equipment market is set to gain impetus from the rising adoption of next-generation workstations and digital databases equipped with big data analytics, machine learning platforms, and IoT. This information is published by Fortune Business Insights™ in a new study, titled, “Meteorological Equipment Market Size, Share & COVID-19 Impact Analysis, By Product Type (Cold Cloud, Warm Cloud and Mixed Phenomenon), By Application (Detection of Meteorological Conditions, Field Operation, Process Monitoring and Others), By Industry (Aviation, Agriculture, Energy & Utilities and Others) and Regional Forecast, 2020-2027.” The study further mentions that the market size was USD 2.04 billion in 2019 and is projected to reach USD 3.11 billion by 2027, exhibiting a CAGR of...
Roche launches cobas PIK3CA Mutation Test for patients with advanced or metastatic breast cancer in countries accepting the CE mark
Written by Customer Service on . Posted in Public Companies.
This genetic test identifies mutations in the PIK3CA gene that can cause cells to grow uncontrollably, which may lead to cancerPIK3CA is the most commonly mutated gene in advanced or metastatic breast cancer, with nearly 40 percent of patients harbouring a mutation in this gene1The cobas PIK3CA Mutation Test is a PCR-based test that detects PIK3CA mutations in patients with metastatic breast cancer to help identify those most likely to benefit from approved therapy2Basel, 15 December 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® PIK3CA Mutation Test for patients with advanced or metastatic breast cancer. Previously only available as research use only (RUO), this in vitro diagnostic (IVD) test is now available in countries accepting the CE mark. Attachment15122020_MR_PIK3CA
Inbank acquires 53% stake in Mobire, a full-service vehicle rental company
Written by Customer Service on . Posted in Public Companies.
On 14 December 2020, Inbank signed an agreement to acquire 53% of the full-service vehicle rental company Mobire Group OÜ. Parties have agreed not to disclose the price of the transaction.The purpose of the transaction is to strengthen Inbank’s position in the car financing market and enter into an innovative subscription-based business model. The acquisition of a stake in the Mobire Group will not have a significant impact on the economic activities of Inbank. Following the transaction, Mobire will continue to operate under its current name.According to Priit Põldoja, Chairman of the Supervisory Board of Inbank, the world is clearly moving towards a subscription-based business model. “As the subscription-based business can be successfully scaled, we see great growth potential in the full-service vehicle rental business,”...
